Corrigendum: Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132

• Yezhe Cheng,
• Xiaoxi Yuan,
• Qiang Tian,
• Xiuying Huang,
• Yang Chen,
• Yuzhi Pu,
• Hu Long,
• Mingyu Xu,
• Yafei Ji,
• Jia Xie,
• Yuping Tan,
• Xi Zhao,
• Hongmei Song

Affiliations

Yezhe Cheng

Xiaoxi Yuan

Qiang Tian

Xiuying Huang

Yang Chen

Yuzhi Pu

Hu Long

Mingyu Xu

Yafei Ji

Jia Xie

Yuping Tan

Xi Zhao

Hongmei Song